Previous Case Study: SBI
Next Case Study: Labplas



Based in New York, the American company UE LifeSciences has developed the iBreastExam, a sensor-equipped device that performs a breast cancer screening test in just a few minutes. Unlike traditional mammograms, this technology is radiation-free and painless and allows the exam to be performed for a fraction of the cost.

To date, this innovative technology is mainly used in emerging countries such as India, where 90% of women unfortunately do not have access to screening tests. With an efficiency rate of 94%, the iBreastExam makes it possible to identify lesions in the early stages of cancer, which considerably increases patients’ chances of survival.


Minutes required for the patient to obtain her result


The number of deaths related to breast cancer in India, the highest in the world



UE LifeSciences called upon our team to develop the web, mobile, IoT, and cloud components of their solution. The main challenge was to develop a mobile app that would connect to the device via Bluetooth so that the results generated by the iBreastExam could be transmitted to the app in real time.

In addition, because this involves the transfer of sensitive and confidential data, one major concern was to secure the platform to ensure the confidentiality of the results stored in the cloud. To achieve this, we made sure to implement the security and processes required to comply with the Health Insurance Portability and Accountability Act (HIPAA) health standard.



Vooban has developed an app that allows healthcare professionals to record notes, observations, and test results in the cloud. Since internet connections are often unstable in the regions where these tests are performed, the solution is designed to allow all results to be sent to the cloud, even when there is no internet access when the test is performed.

A web app has also been created to facilitate the management of customer accounts. By customers, we mean hospitals, governments, clinics, and physicians as well as the entire ecosystem around them. This ecosystem requires a maximum level of data confidentiality, so we made sure to secure and anonymize the data according to the category of users. In other words, the government can have access to all of its country’s data, while the hospital can only see the results of its patients. Depending on the category the user is in, they can view different types of graphs according to criteria such as demographic region, age groups, symptoms, etc.

Finally, the platform offers the ability to manage clinical records, which allows for appropriate follow-up with patients. In addition, all the tests generate reports in PDF format that can be sent to hospitals to help physicians provide the best treatment.

To this day, more than 400,000 screening tests have been performed in 12 countries around the world, allowing hundreds of cancerous lesions to be detected.